Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Capital Expenditures (2024 - 2025)

Carlsmed's Capital Expenditures history spans 2 years, with the latest figure at $146000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 222.69% year-over-year to $146000.0; the TTM value through Dec 2025 reached $274000.0, changed N/A, while the annual FY2025 figure was $715000.0, N/A changed from the prior year.
  • Capital Expenditures reached $146000.0 in Q4 2025 per CARL's latest filing, down from $195000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $195000.0 in Q3 2025 to a low of -$119000.0 in Q4 2024.